Parikh, Rahul A <br/><br/>
Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features.  [electronic resource] 

 -  Clinical genitourinary cancer  02 2017 
 - 7-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1938-0682 
<br/><br/><label>Standard No.: </label>10.1016/j.clgc.2016.05.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Decision-Making<br/>Clinical Trials as Topic<br/>Drug Interactions<br/>Humans<br/>Kidney Neoplasms--drug therapy<br/>Precision Medicine<br/>Protein Kinase Inhibitors--pharmacology<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Treatment Outcome